Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis

Gabriel Châteauneuf1, Tamim M Nazif2, Frédéric Beaupré1

  • 1Cardiology, Quebec Heart and Lung Institute, Quebec, Quebec, Canada.

Insights

Transcatheter mitral valve interventions show low cerebrovascular event rates. Further research is needed to understand stroke mechanisms after mitral valve clip repair and transcatheter mitral valve replacement.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Neurology

Background:

  • Transcatheter mitral valve interventions are increasingly used for high-risk patients with mitral valvulopathy.
  • Cerebrovascular events are a potential concern following these cardiac procedures.

Purpose of the Study:

  • To systematically review and meta-analyze the incidence of cerebrovascular events after transcatheter mitral valve edge-to-edge repair (MTEER) using a mitral valve clip and transcatheter mitral valve replacement (TMVR).

Main Methods:

  • A systematic review and meta-analysis of studies reporting cerebrovascular events post-MTEER and TMVR.
  • Primary endpoint: incidence of cerebrovascular events (periprocedural and non-periprocedural) as defined by the Mitral Valve Academic Research Consortium.
  • Data pooled using a random effect model; study quality assessed with the Hawker checklist.

Main Results:

  • Analysis of 60 studies (28,155 patients) for MTEER: periprocedural stroke rate 0.9%, non-periprocedural stroke rate 2.4%.
  • Analysis of 26 studies (1,910 patients) for TMVR: periprocedural stroke rate 1%, non-periprocedural stroke rate 7%.
  • Overall, transcatheter mitral valve interventions demonstrated low periprocedural stroke rates.

Conclusions:

  • Transcatheter mitral valve interventions are associated with low rates of cerebrovascular events.
  • Mechanisms underlying these cerebrovascular complications require further investigation due to limited high-quality data.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
178
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
197
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
154
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
269
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
282
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
235